Eli Lilly And Company (LLY): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Eli Lilly and Company ( LLY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.7%. By the end of trading, Eli Lilly and Company rose $0.76 (1.4%) to $53.97 on light volume. Throughout the day, 4,084,337 shares of Eli Lilly and Company exchanged hands as compared to its average daily volume of 5,623,800 shares. The stock ranged in a price between $52.29-$53.98 after having opened the day at $52.79 as compared to the previous trading day's close of $53.21. Other companies within the Health Care sector that increased today were: Ohr Pharmaceutical ( OHRP), up 15.9%, Cara Therapeutics ( CARA), up 15.5%, Aoxing Pharmaceutical Company ( AXN), up 15.3% and Galectin Therapeutics ( GALT), up 14.7%.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. Eli Lilly and Company has a market cap of $59.4 billion and is part of the drugs industry. Shares are up 4.3% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Eli Lilly and Company a buy, 4 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Eli Lilly and Company as a buy. Among the primary strengths of the company is its expanding profit margins over time. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Reliv' International ( RELV), down 9.2%, Prana Biotechnology ( PRAN), down 7.9%, Dynatronics Corporation ( DYNT), down 6.7% and ZELTIQ Aesthetics ( ZLTQ), down 5.6%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk